Cargando…

Stability of the gut microbiota in persons with paediatric-onset multiple sclerosis and related demyelinating diseases

OBJECTIVE: Examine if the gut microbiota composition changes across repeated samples in paediatric-onset multiple sclerosis (MS) or monophasic-acquired demyelinating syndromes (monoADS). METHODS: A total of 36 individuals (18 MS/18 monoADS) with ⩾2 stool samples were included. Stool sample-derived D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Geoffrey, Zhu, Feng, Mirza, Ali I, Bar-Or, Amit, Bernstein, Charles N, Bonner, Christine, Forbes, Jessica D, Graham, Morag, Hart, Janace, Knox, Natalie C, Marrie, Ruth Ann, O’Mahony, Julia, Van Domselaar, Gary, Yeh, E Ann, Zhao, Yinshan, Banwell, Brenda, Waubant, Emmanuelle, Tremlett, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Short Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442770/ https://www.ncbi.nlm.nih.gov/pubmed/35296164 http://dx.doi.org/10.1177/13524585221079533

Ejemplares similares

The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes
por: Tremlett, Helen, et al.
Publicado: (2021)

Comparison of Spinal Cord Magnetic Resonance Imaging Features Among Children With Acquired Demyelinating Syndromes
por: Fadda, Giulia, et al.
Publicado: (2021)

Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes
por: Waters, Patrick, et al.
Publicado: (2019)

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course
por: Nourbakhsh, Bardia, et al.
Publicado: (2018)

The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parents
por: O’Mahony, Julia, et al.
Publicado: (2022)

Family health conditions and parental occupational status modify the relationship between pediatric-onset multiple sclerosis and parental health-related quality of life
por: O’Mahony, Julia, et al.
Publicado: (2023)

High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study
por: Marrie, Ruth Ann, et al.
Publicado: (2019)

Patterns of white and gray structural abnormality associated with paediatric demyelinating disorders
por: Bells, Sonya, et al.
Publicado: (2022)

Physical activity and dentate gyrus volume in pediatric acquired demyelinating syndromes
por: Longoni, Giulia, et al.
Publicado: (2018)

A Fungal World: Could the Gut Mycobiome Be Involved in Neurological Disease?
por: Forbes, Jessica D., et al.
Publicado: (2019)

Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria
por: Fadda, Giulia, et al.
Publicado: (2022)

A surface‐in gradient of thalamic damage evolves in pediatric multiple sclerosis
por: Fadda, Giulia, et al.
Publicado: (2019)

Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls
por: Tremlett, Helen, et al.
Publicado: (2016)

Preventing Multiple Sclerosis: The Pediatric Perspective
por: Hardy, Duriel, et al.
Publicado: (2022)

Treatment Approaches for MOG-Ab-Associated Demyelination in Children
por: Hacohen, Yael, et al.
Publicado: (2019)

Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS
por: Deiva, Kumaran, et al.
Publicado: (2020)

A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist?
por: Forbes, Jessica D., et al.
Publicado: (2018)

Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study
por: Krupp, Lauren, et al.
Publicado: (2022)

Assessment of Inter-Laboratory Variation in the Characterization and Analysis of the Mucosal Microbiota in Crohn’s Disease and Ulcerative Colitis
por: Szamosi, Jake C., et al.
Publicado: (2020)

Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits
por: Graf, Jonas, et al.
Publicado: (2022)

Neuroinflammatory and Demyelinating Disorders of Childhood
por: Nouri, Maryam Nabavi, et al.
Publicado: (2020)

Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study
por: Arnold, Douglas L, et al.
Publicado: (2020)

Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children
por: Razaz, Neda, et al.
Publicado: (2016)

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival
por: Ng, Huah Shin, et al.
Publicado: (2022)

Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
por: Graf, Jonas, et al.
Publicado: (2023)

Microbiome-Mediated Immune Signaling in Inflammatory Bowel Disease and Colorectal Cancer: Support From Meta-omics Data
por: Pratt, Molly, et al.
Publicado: (2021)

Disease-modifying drugs for multiple sclerosis and subsequent health service use
por: Ng, Huah Shin, et al.
Publicado: (2021)

Physical and Mental Health–Related Quality of Life Trajectories Among People With Multiple Sclerosis
por: O'Mahony, Julia, et al.
Publicado: (2022)

Sex and age differences in the Multiple Sclerosis prodrome
por: Yusuf, Fardowsa L. A., et al.
Publicado: (2022)

Children and adolescents adjustment to parental multiple sclerosis: a systematic review
por: Razaz, Neda, et al.
Publicado: (2014)

Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children
por: Longoni, Giulia, et al.
Publicado: (2014)

Paediatric UK demyelinating disease longitudinal study (PUDDLS)
por: Absoud, Michael, et al.
Publicado: (2011)

Memory, processing of emotional stimuli, and volume of limbic structures in pediatric-onset multiple sclerosis
por: Fabri, Tracy L., et al.
Publicado: (2021)

A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada
por: McKay, Kyla, et al.
Publicado: (2017)

The challenge of comorbidity in clinical trials for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Alopecia Areata and Demyelination as Paraneoplastic Manifestation in Paediatric Hodgkin's Lymphoma
por: Kanaparthi, Shravan, et al.
Publicado: (2018)

Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood
por: Bruijstens, Arlette L, et al.
Publicado: (2022)

Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population
por: Ng, Huah Shin, et al.
Publicado: (2022)

The Gut Microbiota in Immune-Mediated Inflammatory Diseases
por: Forbes, Jessica D., et al.
Publicado: (2016)

Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG
por: Waubant, Emmanuelle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4s1bpjaslqre1tlfu0cd1kbceg